AVE(SH:688067) Xin Lang Cai Jing·2025-09-23 02:41Group 1 - The core point of the news is that Aiwei Technology's stock has experienced a decline of 5.25% on September 23, with a total market value of 1.645 billion yuan and a cumulative drop of 3.44% over three consecutive days [1] - Aiwei Technology, established on March 16, 2000, and listed on June 16, 2021, specializes in the research, production, sales, and service of medical clinical testing analysis instruments and related in vitro diagnostic reagents and medical consumables [1] - The revenue composition of Aiwei Technology includes reagents at 45.63%, instruments at 34.53%, consumables at 17.56%, and others at 2.28% [1] Group 2 - According to data, the top circulating shareholder of Aiwei Technology is the Nuoan Multi-Strategy Mixed A Fund (320016), which entered the top ten shareholders in the second quarter with 477,400 shares, accounting for 0.7% of circulating shares [2] - The estimated floating loss for the Nuoan Multi-Strategy Mixed A Fund today is approximately 639,700 yuan, with a floating loss of 434,400 yuan during the three-day decline [2] - The Nuoan Multi-Strategy Mixed A Fund has a total scale of 1.399 billion yuan and has achieved a return of 57.56% this year, ranking 694 out of 8,172 in its category [2] Group 3 - The fund managers of Nuoan Multi-Strategy Mixed A are Kong Xianzheng and Wang Haichang, with Kong having a tenure of 4 years and 302 days and a best fund return of 72.6% during his tenure [3] - Wang Haichang has a tenure of 3 years and 64 days, with a best fund return of 60.45% during his tenure [3]